Cephalexin 500 mg Four Times Daily vs 1000 mg Three Times Daily for the Treatment of Uncomplicated Cellulitis
Open Forum Infectious Diseases · 31.10.2026 · 13 (11)
DOI: 10.1093/ofid/ofag681 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 14.10.2026. Verfasst von Erin T Ruiter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, USA. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Cephalexin is a commonly prescribed agent for uncomplicated cellulitis. The currently recommended cellulitis dosing for cephalexin is 500 mg 4 times daily (QID), although QID dosing can be burdensome and literature has suggested that increased dosing frequency leads to decreased adherence. In practice, some clinicians have moved to prescribing cephalexin 1000 mg 3 times daily (TID) to improve feasibility and adherence.
Methods
This retrospective, multicenter cohort study evaluated adult patients who were diagnosed with uncomplicated lower extremity cellulitis and prescribed either cephalexin 500 mg QID or 1000 mg TID for a total of 5 to 10 days. The primary outcome was to compare treatment failure, defined as a composite of change in antimicrobial selection due to documented lack of efficacy or intolerable adverse reaction, with retreatment of cellulitis within 30 days of completion of initial therapy.
Results
Three hundred patients were included (QID, n = 150; TID, n = 150). There was no difference in treatment failure between groups (QID, 6.7%; vs TID, 5.3%; P = .627). Time to treatment failure (interquartile range) was similar between groups (QID, 7 [3–8] days; vs TID, 5 [2.5–8] days; P = .633). There was no difference in unplanned revisit or hospitalization within 30 days between groups (QID, 4%; vs TID, 2.7%; P = .52). Adverse reactions were uncommon and similar between groups (QID, 0%; vs TID, 0.7%; P = 1.0).
Conclusions
Cephalexin 1000 mg TID was well tolerated and as effective as cephalexin dosed 500 mg QID for the treatment of uncomplicated cellulitis. A thrice-daily dosing strategy may improve patient adherence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, USA.
- Division of Infectious Diseases, Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, USA.
- College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.
ORCID-Profile: Kristen M Eid, Ashlyn M Kiebach, Andrew P Jameson, Lisa E Dumkow
Zitieren
APA
Ruiter, E. T., Eid, K. M., Kiebach, A. M., Harven, L. T., Jameson, A. P., & Dumkow, L. E. (2026). Cephalexin 500 mg Four Times Daily vs 1000 mg Three Times Daily for the Treatment of Uncomplicated Cellulitis. Open Forum Infectious Diseases, 13(11). https://doi.org/10.1093/ofid/ofag681
Vancouver
Ruiter ET, Eid KM, Kiebach AM, Harven LT, Jameson AP, Dumkow LE. Cephalexin 500 mg Four Times Daily vs 1000 mg Three Times Daily for the Treatment of Uncomplicated Cellulitis. Open Forum Infectious Diseases. 2026;13(11). doi:10.1093/ofid/ofag681
BibTeX
@article{Ruiter2026,
author = {Ruiter, Erin T and Eid, Kristen M and Kiebach, Ashlyn M and Harven, Lauren T and Jameson, Andrew P and Dumkow, Lisa E},
title = {Cephalexin 500 mg Four Times Daily vs 1000 mg Three Times Daily for the Treatment of Uncomplicated Cellulitis},
journal = {Open Forum Infectious Diseases},
year = {2026},
volume = {13},
number = {11},
doi = {10.1093/ofid/ofag681}
}
EUVIMED